Medline Reports First Quarter 2026 Results
Medline Inc. reported its first quarter 2026 financial results, showcasing a 10.7% increase in net sales to $7.4 billion from the previous year. However, net income decreased by 25.8% to $239 million due to higher costs and operating expenses, despite increased revenue. The company raised its full year Organic Sales guidance and maintained its Adjusted EBITDA outlook.
NORTHFIELD, Ill., May 06, 2026 (GLOBE NEWSWIRE) — Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care3, today reported its operating results for the three months ended March 28, 2026.